Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391560
Status:
COMPLETED
Last Update Posted:
2018-03-14
First Post:
2006-10-20
Brief Title:
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
Sponsor:
AEterna Zentaris
Organization:
AEterna Zentaris
Organization Data
Organization:
AEterna Zentaris
Class:
INDUSTRY
Study ID:
Perifosine 217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AEterna Zentaris
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None